首页 | 本学科首页   官方微博 | 高级检索  
检索        

转移抑制基因及原癌基因在食管癌的表达及与预后的关系
引用本文:王丰梅,郭新建,韩静琦,冶俊玲,赵文辉.转移抑制基因及原癌基因在食管癌的表达及与预后的关系[J].青海医药杂志,2007,37(5):9-11.
作者姓名:王丰梅  郭新建  韩静琦  冶俊玲  赵文辉
作者单位:青海大学附属医院病理科,810001
摘    要:目的:了解转移抑制基因(nm23-H1)和原癌基因(cerbB-2)在食管鳞癌表达与肿瘤临床、病理各指标间的关系.方法:用免疫组化的方法分析两个基因在91例食管癌(鳞癌84例,腺癌3例,未分化癌4例)的表达. 结果:nm23-H1和CerbB-2染色均定位于细胞浆,两者均与淋巴结转移、预后有显著相关性.在无淋巴结转移组,CerbB-2蛋白表达亦和预后有显著负相关.结论:认为nm23-H1高表达或CerbB-2低表达者,淋巴转移率低,术后生存率高,预后较好, CerbB-2可作为一个独立的预后指标,无论有无淋巴结转移,CerbB-2蛋白高表达预后均差.

关 键 词:食管癌  免疫组化  nm23-H1  CerbB-2

Expression of Antimetastatic Gene nm23-H1 and Carcinoma gene CerbB-2 in Esophageal Carcinoma in relation to prognosis
Wang Feng-mei,Guo Xing-jian,Han Jing-qi,Ye Jun-ling,Zhao Wen-hui.Expression of Antimetastatic Gene nm23-H1 and Carcinoma gene CerbB-2 in Esophageal Carcinoma in relation to prognosis[J].Qinghai Medical Journal,2007,37(5):9-11.
Authors:Wang Feng-mei  Guo Xing-jian  Han Jing-qi  Ye Jun-ling  Zhao Wen-hui
Abstract:Objective:To study the relationship between expression of nm23-H1 and CerbB-2 as well prognosis in esophageal carcinoma.Methods:expression of gene nm23-H1 and CerbB-2 were done by immunohistochemistry in 91 cases of esophageal carcinoma(84 cases of squamous carcinoma,3 cases of adenocarcinoma and 4 cases of undifferentiated small cell carcinoma).Results:Low rate of lymph node metastasis and high long term survival rate were found in the group with high expression of nm23-H1 or low expression of CerbB-2.In negative lymph node metastasis group,the expression of cerbB-2 was related to negative prognosis.Conclusions:There is a good prognosis if high nm23-H1 expression and low CerbB-2 expression were found in patients with esophageal carcinoma;and CerbB-2 can be an independent index as prognosis evaluation.
Keywords:nm23-H1  CerbB-2
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号